For the Inventor, By the Inventor

Enter assignee name

Hoofddorp, Netherlands

Abbvie B.v.

USPTO Granted Patents = 13

% Expired Patents = 46.2

CIPO Patents = 1

EPO Patents = 4

Forward Citations = 19

Loading Chart...

Loading Chart...

15 inventors (with patents filed for the assignee):

Wouter I Iwema Bakker (10 out of 21 patents)

Hein K A C Coolen (9 out of 17 patents)

Maria J P Van Dongen (7 out of 8 patents)

4. Adrian Hobson (7 out of 22 patents)

5. Axel Stoit (5 out of 15 patents)

6. Pieter Smid (4 out of 4 patents)

7. Leonardus A J M Sliedregt (4 out of 4 patents)

8. Jacobus A J Den Hartog (4 out of 4 patents)

9. Nicolas J-l D Leflemme (3 out of 4 patents)

10. Raymond Bronger (3 out of 3 patents)

11. Cornelis G Kruse (2 out of 54 patents)

12. Jan H Reinders (2 out of 4 patents)

13. Josephus H M Lange (1 out of 25 patents)

14. Herman H Van Stuivenberg (1 out of 18 patents)

15. Bernard J Van Vliet (1 out of 11 patents)

13 patents: Sort by Forward Citations

1. RE48301 - Fused heterocyclic derivatives as S1P modulators (2020-11-09),

2. 10807991 - Spiro-cyclic amine derivatives as S1P modulators (2020-10-20),

3. 10179791 - Spiro-cyclic amine derivatives as S1P modulators (2019-01-15),

4. 9951084 - Spiro-cyclic amine derivatives as S1P modulators (2018-04-24),

5. 9670220 - Fused heterocyclic derivatives as S1P modulators (2017-06-06),

6. 9662337 - Bisaryl (thio)morpholine derivatives as S1P modulators (2017-05-30),

7. 9227960 - Bisaryl (thio)morpholine derivatives as S1P modulators (2016-01-05),

8. 9096612 - Fused heterocyclic derivatives as S1P modulators (2015-08-04),

9. 9029371 - Bisaryl (thio)morpholine derivatives as S1P modulators (2015-05-12),

10. 8937184 - 1H-imidazole derivatives as cannabinoid CB2 receptor modulators (2015-01-20),

11. 8796262 - Fused heterocyclic derivatives as S1P modulators (2014-08-05),

12. 8735388 - Heterocyclic compounds with affinity to muscarinic receptors (2014-05-27),

13. 8586606 - Heterocyclic compounds with affinity to muscarinic receptors (2013-11-19),

AbbVie B.V., headquartered in Hoofddorp, Netherlands, is a global biopharmaceutical company focused on developing innovative therapies for complex diseases. The organization specializes in areas such as immunology, oncology, neuroscience, and virology, leveraging advanced research and technology to address unmet medical needs. With a commitment to scientific excellence, AbbVie collaborates with healthcare professionals and researchers worldwide to enhance patient outcomes and advance the field of medicine.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

13 Patents

#11 in Hoofddorp

#507 in Netherlands

#44,950 in the World

Hoofddorp, Netherlands

Abbvie B.v.

Forward Citations = 19

15 inventors:

Wouter I Iwema Bakker (10 out of 21 patents)

Hein K A C Coolen (9 out of 17 patents)

Maria J P Van Dongen (7 out of 8 patents)

4. Adrian Hobson (7 out of 22 patents)

5. Axel Stoit (5 out of 15 patents)

Please report any incorrect information to [email protected]

Loading…